International Prognostic Scoring System-Molecular Changes Clinical Management
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, June 16, 2023 -- Implementing the International Prognostic Scoring System-Molecular (IPSS-M) in clinical practice could impact clinical management for nearly half of patients with myelodysplastic syndromes (MDS), according to a study published online May 18 in Frontiers in Oncology.
Irene Zamanillo, from University Hospital 12 Octubre in Madrid, and colleagues analyzed clinical, cytogenetic, and molecular data from 166 MDS patients. IPSS-Revised and IPSS-M were calculated and survival was assessed.
The researchers found that 86.1 percent of patients had at least one genetic alteration, including most frequently SF3B1 (25.9 percent), DNMT3A (16.8 percent), and ASXL1 (14.4 percent). Nearly half of patients (48.2 percent) were restratified with IPSS-M, including 16.9 percent who were downgraded and 31.3 percent who were upgraded. For overall survival, IPSS-M improved outcome prediction with a Harrell’s c-index of 0.680 versus 0.626, and 0.801 versus 0.757 for leukemia-free survival. For nearly one-quarter of patients (22.2 percent), the reclassification of the IPSS-M could potentially affect clinical management, with 17.4 percent eligible for treatment intensification and 4.8 percent for treatment reduction.
"IPSS-M implementation in clinical practice could imply different treatment approaches in a significant number of patients," the authors write. "Our work validates IPSS-M in an external cohort and confirms its applicability in a real-life setting."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer
FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.